Cited by 507Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisProtease and Inhibitor MechanismsPulmonary Hypertension Research and Treatments

The DOI matches its Crossref record; 212 of the 212 references it cites were found in a registry or an index.

Matrix Metalloproteinases as Therapeutic Targets for Idiopathic Pulmonary Fibrosis

Open access

Craig, Vanessa J., Zhang, Li, Hagood, James S., Owen, Caroline A.·2015·American Journal of Respiratory Cell and Molecular Biology

DOI 10.1165/rcmb.2015-0020trPMC PMC4742954

Open this paper in CoChat — free account

Abstract

Idiopathic pulmonary fibrosis (IPF) is a restrictive lung disease that is associated with high morbidity and mortality. Current medical therapies are not fully effective at limiting mortality in patients with IPF, and new therapies are urgently needed. Matrix metalloproteinases (MMPs) are proteinases that, together, can degrade all components of the extracellular matrix and numerous nonmatrix proteins. MMPs and their inhibitors, tissue inhibitors of MMPs (TIMPs), have been implicated in the pathogenesis of IPF based upon the results of clinical studies reporting elevated levels of MMPs (including MMP-1, MMP-7, MMP-8, and MMP-9) in IPF blood and/or lung samples. Surprisingly, studies of gene-targeted mice in murine models of pulmonary fibrosis (PF) have demonstrated that most MMPs promote (rather than inhibit) the development of PF and have identified diverse mechanisms involved. These mechanisms include MMPs: (1) promoting epithelial-to-mesenchymal transition (MMP-3 and MMP-7); (2) increasing lung levels or activity of profibrotic mediators or reducing lung levels of antifibrotic mediators (MMP-3, MMP-7, and MMP-8); (3) promoting abnormal epithelial cell migration and other aberrant repair processes (MMP-3 and MMP-9); (4) inducing the switching of lung macrophage phenotypes from M1 to M2 types (MMP-10 and MMP-28); and (5) promoting fibrocyte migration (MMP-8). Two MMPs, MMP-13 and MMP-19, have antifibrotic activities in murine models of PF, and two MMPs, MMP-1 and MMP-10, have the potential to limit fibrotic responses to injury. Herein, we review what is known about the contributions of MMPs and TIMPs to the pathogenesis of IPF and discuss their potential as therapeutic targets for IPF.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1165/rcmb.2015-0020tr

Cites

212 of 212 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761
A matrix metalloproteinase expressed on the surface of invasive tumour cells
Sato, H., Takino, T., Okada, Y., Cao, J. P., Shinagawa, A., Yamamoto, E., & Seiki, M. (1994) · Nature · doi:10.1038/370061a0 · Cited by 2,547
Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase
Strongin, A. Y., Collier, I. E., Bannikov, G. A., Marmer, B. L., Grant, G. A., & Goldberg, G. I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5331 · Cited by 1,605
Regulation of matrix metalloproteinase expression in tumor invasion
Westermarck, J. K., & Kähäri, V. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.8.781 · Cited by 1,494
The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family.
Van Wart, H. E., & Birkedal-Hansen, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5578 · Cited by 1,475
MT1-MMP-Deficient Mice Develop Dwarfism, Osteopenia, Arthritis, and Connective Tissue Disease due to Inadequate Collagen Turnover
Holmbeck, K., Bianco, P., Caterina, J., Yamada, S., Kromer, M., Kuznetsov, S. A., Mankani, M., Gehron Robey, P., Poole, A. R., Pidoux, I., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80064-1 · Cited by 1,298
Regulation of matrix metalloproteinases: An overview
Chakraborti, S., Mandal, M., Das, S. K., Mandal, A., & Chakraborti, T. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1026028303196 · Cited by 1,123

Show all 210 references

Sorted by citations

Fibrosis: from mechanisms to medicines
Henderson, N. C., Rieder, F., & Wynn, T. A. (2020) · Nature · doi:10.1038/s41586-020-2938-9 · Cited by 1,868
Senescence and aging: Causes, consequences, and therapeutic avenues
McHugh, D., & Gil, J. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201708092 · Cited by 1,233
Inflammation and immunity in IPF pathogenesis and treatment
Heukels, P., Moor, C. C., von der Thüsen, J. H., Wijsenbeek, M. S., & Kool, M. (2019) · Respiratory Medicine · doi:10.1016/j.rmed.2018.12.015 · Cited by 549
The big five in fibrosis: Macrophages, myofibroblasts, matrix, mechanics, and miscommunication
Pakshir, P., & Hinz, B. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.01.019 · Cited by 396
Macrophage and Fibroblast Interactions in Biomaterial‐Mediated Fibrosis
Witherel, C. E., Abebayehu, D., Barker, T. H., & Spiller, K. L. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801451 · Cited by 374
Immune mechanisms in pulmonary fibrosis
Kolahian, S., Fernandez, I. E., Eickelberg, O., & Hartl, D. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0121tr · Cited by 349
Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics
Raeeszadeh‐Sarmazdeh, M., Do, L., & Hritz, B. (2020) · Cells · doi:10.3390/cells9051313 · Cited by 342
Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets
Hewlett, J. C., Kropski, J. A., & Blackwell, T. S. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.03.021 · Cited by 334
Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets
Ballester, B., Milara, J., & Cortijo, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030593 · Cited by 318
Oxidative Stress in Pulmonary Fibrosis
Otoupalova, E., Smith, S., Cheng, G., & Thannickal, V. J. (2020) · Comprehensive physiology · doi:10.1002/cphy.c190017 · Cited by 312
Biophysics of tumor microenvironment and cancer metastasis – a mini review
Emon, B., Bauer, J., Jain, Y., Jung, B., & Saif, T. (2018) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2018.07.003 · Cited by 245
The Processes and Mechanisms of Cardiac and Pulmonary Fibrosis
Murtha, L. A., Schuliga, M. J., Mabotuwana, N. S., Hardy, S. A., Waters, D. W., Burgess, J. K., Knight, D. A., & Boyle, A. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00777 · Cited by 235
WNT Signaling in Disease
Li, N., Kaur, P., Bunnag, N., Suresh, J., Sung, I. C. H., Tan, Q. H., Gruber, J., & Tolwinski, N. S. (2019) · Cells · doi:10.3390/cells8080826 · Cited by 228
COVID-19 and pulmonary fibrosis: a potential role for lung epithelial cells and fibroblasts
John, A. E., Joseph, C., Jenkins, G., & Tatler, A. L. (2021) · Immunological Reviews · doi:10.1111/imr.12977 · Cited by 219
Host–Microbial Interactions in Idiopathic Pulmonary Fibrosis
Molyneaux, P. L., Willis‐Owen, S. A. G., Cox, M. J., James, P. L., Cowman, S. A., Loebinger, M. R., Blanchard, A. D., Edwards, L. M., Stock, C. J. W., Daccord, C., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201607-1408oc · Cited by 222
Neutrophils: a cornerstone of liver ischemia and reperfusion injury
de Oliveira, T. H. C., Marques, P. E., Proost, P., & Teixeira, M. M. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.90 · Cited by 217
Therapeutic approaches to control tissue repair and fibrosis: Extracellular matrix as a game changer
Walraven, M., & Hinz, B. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.02.020 · Cited by 199
Regeneration or Repair? The Role of Alveolar Epithelial Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF)
Confalonieri, P., Volpe, M. C., Jacob, J., Maiocchi, S., Salton, F., Ruaro, B., Confalonieri, M., & Braga, L. (2022) · Cells · doi:10.3390/cells11132095 · Cited by 185
Mechanochemical Signaling of the Extracellular Matrix in Epithelial-Mesenchymal Transition
Scott, L. E., Weinberg, S. H., & Lemmon, C. A. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00135 · Cited by 165
Traditional Chinese medicine for pulmonary fibrosis therapy: Progress and future prospects
Li, L., & Kan, L. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.12.042 · Cited by 149
Matrix metalloproteinases in emphysema
Gharib, S. A., Manicone, A. M., & Parks, W. C. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.01.018 · Cited by 151
Conventional and pathogenic Th2 cells in inflammation, tissue repair, and fibrosis
Kokubo, K., Onodera, A., Kiuchi, M., Tsuji, K., Hirahara, K., & Nakayama, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.945063 · Cited by 155
Alveolar and lung interstitial macrophages: Definitions, functions, and roles in lung fibrosis
Shi, T., Denney, L., An, H., Ho, L., & Zheng, Y. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ru0720-418r · Cited by 146
Biomarkers in idiopathic pulmonary fibrosis
Drakopanagiotakis, F., Wujak, L., Wygrecka, M., & Markart, P. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.01.023 · Cited by 132
Matrix metalloproteinase: An upcoming therapeutic approach for idiopathic pulmonary fibrosis
Mahalanobish, S., Saha, S., Dutta, S., & Sil, P. C. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104591 · Cited by 131
Collagen Biosynthesis, Processing, and Maturation in Lung Ageing
Onursal, C., Dick, E., Angelidis, I., Schiller, H. B., & Staab-Weijnitz, C. A. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.593874 · Cited by 132
Immune Mechanisms of Pulmonary Fibrosis with Bleomycin
Ishida, Y., Kuninaka, Y., Mukaida, N., & Kondo, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043149 · Cited by 129
Reviewing the Regulators of COL1A1
Devos, H., Zoidakis, J., Roubelakis, M. G., Latosinska, A., & Vlahou, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210004 · Cited by 119
Matrix Metalloproteinases and Their Inhibitors in Pulmonary Fibrosis: EMMPRIN/CD147 Comes into Play
Chuliá‐Peris, L., Carreres-Rey, C., Gabasa, M., Alcaraz, J., Carretero, J., & Pereda, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23136894 · Cited by 126
Macrophages in lung fibrosis
Ogawa, T., Shichino, S., Ueha, S., & Matsushima, K. (2021) · International Immunology · doi:10.1093/intimm/dxab040 · Cited by 113
The Role of Fibrosis in Osteoarthritis Progression
Rim, Y. A., & Ju, J. H. (2020) · Life · doi:10.3390/life11010003 · Cited by 113
Proteomic biomarkers of progressive fibrosing interstitial lung disease: a multicentre cohort analysis
Bowman, W. S., Newton, C. A., Linderholm, A., Neely, M. L., Pugashetti, J. V., Kaul, B., Vo, V., Echt, G., Leon, W., Shah, R., et al. (2022) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00503-8 · Cited by 112
Cartilage-Related Collagens in Osteoarthritis and Rheumatoid Arthritis: From Pathogenesis to Therapeutics
Ouyang, Z., Dong, L., Feng, Y., Wang, K., Chen, Y., Li, S., Zhou, R., Zhao, Y., & Hu, W. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129841 · Cited by 129
Interplay of extracellular matrix and leukocytes in lung inflammation
Wight, T. N., Frevert, C. W., Debley, J. S., Reeves, S. R., Parks, W. C., & Ziegler, S. F. (2016) · Cellular Immunology · doi:10.1016/j.cellimm.2016.12.003 · Cited by 105
Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort
on behalf of the IPF-PRO Registry investigators, Todd, J. L., Vinisko, R., Liu, Y., Neely, M. L., Overton, R. A., Flaherty, K. R., Noth, I., Newby, L. K., Lasky, J. A., et al. (2020) · BMC Pulmonary Medicine · doi:10.1186/s12890-020-1103-4 · Cited by 105
Silica particles disorganize the polarization of pulmonary macrophages in mice
Zhao, Y., Hao, C., Bao, L., Wang, D., Li, Y., Qu, Y., Ding, M., Zhao, A., & Yao, W. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.110364 · Cited by 104
Metabolic characterization and RNA profiling reveal glycolytic dependence of profibrotic phenotype of alveolar macrophages in lung fibrosis
Xie, N., Cui, H., Ge, J., Banerjee, S., Guo, S., Dubey, S., Abraham, E. H., Liu, R.-M., & Liu, G. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00235.2017 · Cited by 102
Is the Macrophage Phenotype Determinant for Fibrosis Development?
Lis-López, L., Bauset, C., Seco-Cervera, M., & Cosín‐Roger, J. (2021) · Biomedicines · doi:10.3390/biomedicines9121747 · Cited by 104
Advances in pathogenic mechanisms and management of radiation-induced fibrosis
Wang, B., Wei, J., Meng, L., Wang, H., Qu, C., Chen, X., Xin, Y., & Jiang, X. M. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109560 · Cited by 100
Ferulic Acid: A Review of Pharmacology, Toxicology, and Therapeutic Effects on Pulmonary Diseases
Zhai, Y., Wang, T., Fu, Y., Yu, T., Ding, Y. P., & Nie, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098011 · Cited by 98
Club Cell Protein 16 (CC16) Augmentation: A Potential Disease-modifying Approach for Chronic Obstructive Pulmonary Disease (COPD)
Laucho-Contreras, M. E., Polverino, F., Tesfaigzi, Y., Pilon, A. L., Celli, B. R., & Owen, C. A. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1139084 · Cited by 95
Self-citation
Matrix metalloproteinases: Expression, regulation and role in the immunopathology of tuberculosis
Sabir, N., Hussain, T. A., Mangi, M. H., Zhao, D., & Zhou, X. (2019) · Cell Proliferation · doi:10.1111/cpr.12649 · Cited by 100
Xuanfei Baidu Decoction protects against macrophages induced inflammation and pulmonary fibrosis via inhibiting IL-6/STAT3 signaling pathway
Wang, Y., Sang, X., Shao, R., Qin, H., Chen, X., Xue, Z., Li, L., Wang, Y., Zhu, Y., Chang, Y., et al. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114701 · Cited by 90
Influences of innate immunity, autophagy, and fibroblast activation in the pathogenesis of lung fibrosis
O’Dwyer, D. N., Ashley, S. L., & Moore, B. B. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00221.2016 · Cited by 90
microRNA let-7 Downregulates Ligand Independent Estrogen Receptor Mediated Male Predominant Pulmonary Fibrosis.
Elliot, S., Periera-Simon, S., Xia, X., Catanuto, P., Rubio, G., Shahzeidi, S., Salem, F. E., Shapiro, J., Briegel, K. J., Korach, K., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201903-0508oc · Cited by 74
Fighting the Fiber: Targeting Collagen in Lung Fibrosis
Staab-Weijnitz, C. A. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2021-0342tr · Cited by 86
SARS-CoV-2-triggered mast cell rapid degranulation induces alveolar epithelial inflammation and lung injury
Wu, M., Liu, F., Sun, J., Li, X., He, X.-Y., Zheng, H., Pei, R., Sun, H., Zhou, Y.-H., Yan, Q., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00849-0 · Cited by 86
Regulatory Immune Cells in Idiopathic Pulmonary Fibrosis: Friends or Foes?
van Geffen, C., Deißler, A., Quante, M., Renz, H. E., Hartl, D., & Kolahian, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.663203 · Cited by 82
Promising Biomarkers of Radiation-Induced Lung Injury: A Review
Liu, X., Shao, C., & Fu, J. (2021) · Biomedicines · doi:10.3390/biomedicines9091181 · Cited by 75
Is there a role for IL-17 in the pathogenesis of systemic sclerosis?
Chizzolini, C., Dufour, A. M., & Brembilla, N. C. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.09.007 · Cited by 74
Combinatorial treatment of idiopathic pulmonary fibrosis using nanoparticles with prostaglandin E and siRNA(s)
Garbuzenko, O. B., Ivanova, V., Kholodovych, V., Reimer, D. C., Reuhl, K. R., Yurkow, E. J., Adler, D., & Minko, T. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.04.005 · Cited by 74
The impaired proteases and anti-proteases balance in Idiopathic Pulmonary Fibrosis
Menou, A., Duitman, J., & Crestani, B. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.03.001 · Cited by 72
Review: Serum biomarkers in idiopathic pulmonary fibrosis and systemic sclerosis associated interstitial lung disease – frontiers and horizons
Jee, A. S., Sahhar, J., Youssef, P. P., Bleasel, J. F., Adelstein, S., Nguyen, M., & Corte, T. J. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.05.014 · Cited by 76
Investigating the possible mechanisms of pirfenidone to be targeted as a promising anti-inflammatory, anti-fibrotic, anti-oxidant, anti-apoptotic, anti-tumor, and/or anti-SARS-CoV-2
Antar, S. A., Saleh, M. A., & Al-Karmalawy, A. A. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121048 · Cited by 73
Interferon-γ enhances the antifibrotic effects of pirfenidone by attenuating IPF lung fibroblast activation and differentiation
Vu, T. N., Chen, X., Foda, H. D., Smaldone, G. C., & Hasaneen, N. A. (2019) · Respiratory Research · doi:10.1186/s12931-019-1171-2 · Cited by 73
Dynamic human liver proteome atlas reveals functional insights into disease pathways
Niu, L., Geyer, P. E., Gupta, R., Santos, A., Meier, F., Doll, S., Albrechtsen, N. J. W., Klein, S., Ortiz, C., Uschner, F. E., et al. (2022) · Molecular Systems Biology · doi:10.15252/msb.202210947 · Cited by 67
The fibrogenic actions of the coagulant and plasminogen activation systems in pulmonary fibrosis
Schuliga, M. J., Grainge, C., Westall, G. P., & Knight, D. A. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.02.016 · Cited by 71
The emerging roles of interstitial macrophages in pulmonary fibrosis: A perspective from scRNA-seq analyses
Gu, Y., Lawrence, T., Mohamed, R., Liang, Y., & Yahaya, B. H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.923235 · Cited by 73
Macrophage-derived MMP12 promotes fibrosis through sustained damage to endothelial cells
Zhou, X., Zhang, C., Yang, S., Yang, L., Luo, W. F., Zhang, W., Zhang, X., & Chao, J. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.132733 · Cited by 69
The role of macrophage polarization and cellular crosstalk in the pulmonary fibrotic microenvironment: a review
Zhou, B., Liu, H., Xu, F., & Jia, X. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01557-2 · Cited by 74
Current Concepts of Biliary Atresia and Matrix Metalloproteinase-7: A Review of Literature
Nomden, M., Beljaars, L., Verkade, H. J., Hulscher, J. B. F., & Olinga, P. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.617261 · Cited by 64
Transforming growth factor beta1 targets estrogen receptor signaling in bronchial epithelial cells
Smith, L. C., Moreno-Caceres, S., Robertson, L. T., Robinson, S., Gant, K. L., Bryant, A. J., & Sabo‐Attwood, T. (2018) · Respiratory Research · doi:10.1186/s12931-018-0861-5 · Cited by 64
Systems level identification of a matrisome-associated macrophage polarisation state in multi-organ fibrosis
Huang, K. Y., Mishra, K., Park, H., Yi, X., Ouyang, J. F., Petretto, E. G., & Behmoaras, J. V. (2023) · eLife · doi:10.7554/elife.85530 · Cited by 68
Role of ADAM and ADAMTS proteases in pathological tissue remodeling
Wang, Z.-N., Li, W., Chen, S., & Tang, X. X. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01744-z · Cited by 61
Fibroproliferative genes are preferentially expressed in central centrifugal cicatricial alopecia
Aguh, C., Dina, Y., Talbot, C. C., & Garza, L. A. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.05.1257 · Cited by 61
Effects of β-Sitosterol from Corn Silk on TGF-β1-Induced Epithelial–Mesenchymal Transition in Lung Alveolar Epithelial Cells
Park, Y. J., Bang, I. J., Jeong, M. H., Kim, H. R., Lee, D. E., Kwak, J. H., & Chung, K. H. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b02730 · Cited by 61
Polarity and epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy
Zou, H., Shan, C., Ma, L., Liu, J., Yang, N., & Zhao, J. (2020) · PeerJ · doi:10.7717/peerj.10136 · Cited by 59
Glycyrrhizic acid alleviates bleomycin-induced pulmonary fibrosis in rats
Gao, L., Tang, H., He, H., Liu, J., Mao, J., Ji, H. L., Lin, H., & Wu, T. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00215 · Cited by 59
Inhaled mRNA Nanoformulation with Biogenic Ribosomal Protein Reverses Established Pulmonary Fibrosis in a Bleomycin‐Induced Murine Model
Zhang, R., Jing, W., Chen, C., Zhang, S., Abdalla, M., Sun, P., Wang, G., You, W., Yang, Z., Zhang, J., et al. (2022) · Advanced Materials · doi:10.1002/adma.202107506 · Cited by 58
Cell Cross-Talk in Alveolar Microenvironment: From Lung Injury to Fibrosis
Song, L., Li, K., Chen, H., & Xie, L. (2024) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2023-0426tr · Cited by 64
Pulmonary toxicants and fibrosis: innate and adaptive immune mechanisms
Malaviya, R., Kipen, H. M., Businaro, R., Laskin, J. D., & Laskin, D. L. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115272 · Cited by 58
Mechanosensitive Regulation of Fibrosis
Yang, S., & Plotnikov, S. V. (2021) · Cells · doi:10.3390/cells10050994 · Cited by 58
Matrix metalloproteinase-9 deficiency protects mice from severe influenza A viral infection
Rojas, J., Wang, X., Tipper, J. L., Burkett, P. R., Zúñiga, J., Ashtekar, A. R., Polverino, F., Rout, A., Yambayev, I., Hernández, C., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.99022 · Cited by 57
Self-citation
Extracellular matrix remodeling in idiopathic pulmonary fibrosis. It is the ‘bed’ that counts and not ‘the sleepers’
Tomos, I. P., Tzouvelekis, A., Aidinis, V., Manali, E. D., Bouros, E., Bouros, D. E., & Papiris, S. A. (2017) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2017.1300533 · Cited by 52
Early Plasma Matrix Metalloproteinase Profiles: A Novel Pathway in Pediatric Acute Respiratory Distress Syndrome
Zinter, M. S., Delucchi, K., Kong, M. Y. F., Orwoll, B., Spicer, A. C., Lim, M., Alkhouli, M. F., Ratiu, A., McKenzie, A. V., McQuillen, P. S., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201804-0678oc · Cited by 53
Differential Responses to Targeting Matrix Metalloproteinase 9 in Idiopathic Pulmonary Fibrosis
Espíndola, M. S., Habiel, D. M., Coelho, A. L., Stripp, B. R., Parks, W. C., Oldham, J. M., Martínez, F. J., Noth, I., Lopez, D., Mikels, A. J., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201910-1977oc · Cited by 52
Toxicogenomics Data for Chemical Safety Assessment and Development of New Approach Methodologies: An Adverse Outcome Pathway‐Based Approach
Saarimäki, L. A., Morikka, J., Pavel, A., Korpilähde, S., del Giudice, G., Federico, A., Fratello, M., Serra, A., & Greco, D. (2022) · Advanced Science · doi:10.1002/advs.202203984 · Cited by 62
The Role of Immune Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis
Xu, Y., Lan, P., & Wang, T. (2023) · Medicina · doi:10.3390/medicina59111984 · Cited by 58
The current landscape of antifibrotic therapy across different organs: A systematic approach
Fuster‐Martínez, I., & Calatayud, S. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107245 · Cited by 60
Honokiol: A polyphenol neolignan ameliorates pulmonary fibrosis by inhibiting TGF-β/Smad signaling, matrix proteins and IL-6/CD44/STAT3 axis both in vitro and in vivo
Pulivendala, G., Bale, S., & Godugu, C. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.114913 · Cited by 52
Physiological Properties, Functions, and Trends in the Matrix Metalloproteinase Inhibitors in Inflammation-Mediated Human Diseases
Kim, I.-S., Yang, W., & Kim, C. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220823112731 · Cited by 53
AT-RVD1 repairs mouse lung after cigarette smoke-induced emphysema via downregulation of oxidative stress by NRF2/KEAP1 pathway
Posso, S. V., Quesnot, N., Moraes, J. A., de Brito‐Gitirana, L., Kennedy-Feitosa, E., Barroso, M. V., Pôrto, L. C., Lanzetti, M., & Valença, S. S. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.01.045 · Cited by 52
Relationship between plasma matrix metalloproteinase levels, pulmonary function, bronchodilator response, and emphysema severity
Koo, H., Hong, Y., Lim, M.-N., Yim, J., & Kim, W. J. (2016) · International Journal of COPD · doi:10.2147/copd.s103281 · Cited by 50
Epithelial-interleukin-1 inhibits collagen formation by airway fibroblasts: Implications for asthma
Osei, E. T., Mostaço-Guidolin, L. B., Hsieh, A., Warner, S., Fouadi, M., Wang, M. X., Cole, D. J., Maksym, G. N., Hallstrand, T. S., Timens, W., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-65567-z · Cited by 55
Genome-Wide Association Study: Functional Variant rs2076295 Regulates Desmoplakin Expression in Airway Epithelial Cells
Hao, Y. T., Bates, S., Mou, H., Yun, J. H., Pham, B., Liu, J., Qiu, W., Guo, F., Morrow, J. D., Hersh, C. P., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201910-1958oc · Cited by 47
Dynamic atlas of immune cells reveals multiple functional features of macrophages associated with progression of pulmonary fibrosis
Lv, J., Gao, H., Ma, J., Liu, J., Tian, Y., Yang, C., Li, M., Zhao, Y., Li, Z., Zhang, X., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1230266 · Cited by 48
LRP1: A chameleon receptor of lung inflammation and repair
Wujak, L. A., Schnieder, J., Schaefer, L., & Wygrecka, M. (2017) · Matrix Biology · doi:10.1016/j.matbio.2017.12.007 · Cited by 48
Deciphering the fibrotic process: mechanism of chronic radiation skin injury fibrosis
Wang, Y., Chen, S., Bao, S., Li, Y., Wen, Z., Xu, L., Chen, X., Guo, S., Pang, H., Zhou, Y., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1338922 · Cited by 47
iTRAQ-Based Proteomics Reveals Novel Biomarkers for Idiopathic Pulmonary Fibrosis
Niu, R. L., Liu, Y., Zhang, Y., Zhang, Y., Wang, H., Wang, Y., Wang, W., & Li, X. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170741 · Cited by 46
Global Gene Expression Analysis in an in vitro Fibroblast Model of Idiopathic Pulmonary Fibrosis Reveals Potential Role for CXCL14/CXCR4
Rodríguez, L. R., Emblom-Callahan, M. C., Chhina, M. K., Bui, S., Aljeburry, B., Tran, L. H., Novak, R., Lemma, M., Nathan, S. D., & Grant, G. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-21889-7 · Cited by 48
Insulin-like growth factor (IGF)-II- mediated fibrosis in pathogenic lung conditions
Garrett, S. M., Hsu, E., Thomas, J. M., Pilewski, J. M., & Feghali‐Bostwick, C. A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225422 · Cited by 47
Identification of Key Candidate Genes Involved in the Progression of Idiopathic Pulmonary Fibrosis
Cui, Y. N., Ji, J., Hou, J., Tan, Y., & Han, X. (2021) · Molecules · doi:10.3390/molecules26041123 · Cited by 43
The Matrix Metalloproteinase‐13 Inhibitor Poricoic Acid ZI Ameliorates Renal Fibrosis by Mitigating Epithelial‐Mesenchymal Transition
Chen, L., Cao, G., Wang, M., Feng, Y., Chen, D., Vaziri, N. D., Zhuang, S., & Zhao, Y. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900132 · Cited by 45
Meprin β contributes to collagen deposition in lung fibrosis
Biasin, V., Wygrecka, M., Marsh, L. M., Becker‐Pauly, C., Brčić, L., Ghanim, B., Klepetko, W., Olschewski, A., & Kwapiszewska, G. (2017) · Scientific Reports · doi:10.1038/srep39969 · Cited by 47
Human apical-out nasal organoids reveal an essential role of matrix metalloproteinases in airway epithelial differentiation
Li, L., Jiao, L., Feng, D., Yuan, Y., Yang, X., Li, J., Jiang, D., Chen, H., Meng, Q., Chen, R., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44488-1 · Cited by 43
Involvement of Matrix Metalloproteinases in COVID-19: Molecular Targets, Mechanisms, and Insights for Therapeutic Interventions
Salomão, R., Assis, V., Neto, I. V. D. S., Petriz, B. A., Babault, N., Durigan, J. L. Q., & Marqueti, R. D. C. (2023) · Biology · doi:10.3390/biology12060843 · Cited by 44
Neotuberostemonine attenuates bleomycin-induced pulmonary fibrosis by suppressing the recruitment and activation of macrophages
Xiang, J., Cheng, S., Feng, T., Wu, Y. L., Xie, W., Zhang, M., Xu, X., & Zhang, C. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.04.016 · Cited by 42
Targeting oxidative stress, proinflammatory cytokines, apoptosis and toll like receptor 4 by empagliflozin to ameliorate bleomycin-induced lung fibrosis
Kabel, A. M., Estfanous, R. S., & Alrobaian, M. (2019) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2019.103316 · Cited by 42
PCSK6 and Survival in Idiopathic Pulmonary Fibrosis
Oldham, J. M., Allen, R. J., Lorenzo-Salazar, J. M., Molyneaux, P. L., Ma, S., Joseph, C., Kim, J. S., Guillén‐Guío, B., Hernández-Beeftink, T., Kropski, J. A., et al. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202205-0845oc · Cited by 42
Unsupervised gene expression analyses identify IPF-severity correlated signatures, associated genes and biomarkers
Wang, Y., Yella, J., Chen, J., McCormack, F. X., Madala, S. K., & Jegga, A. G. (2017) · BMC Pulmonary Medicine · doi:10.1186/s12890-017-0472-9 · Cited by 42

Authors: Craig, V. J., Zhang, L., Hagood, J. S., & Owen, C. A.
Affiliations: Brigham and Women's Hospital (US)
University of California San Diego (US)
Corresponding author: Owen, Caroline A.
ORCID: Hagood, James S.
Owen, Caroline A.
Venue: American Journal of Respiratory Cell and Molecular Biology
Publisher: Oxford University Press (OUP)
Published: 2015-11-01
Volume: 53
Issue: 5
Pages: 585-600
ISSN: 1044-1549 (ISSN-L)
1535-4989
DOI: 10.1165/rcmb.2015-0020tr
PMC: PMC4742954
OpenAlex: W1676246072
Cited by: 507
References: 210
Citations by year: 2026: 43 · 2025: 49 · 2024: 60 · 2023: 60 · 2022: 56 · 2021: 60 · 2020: 60 · 2019: 49 · 2018: 28 · 2017: 25 · 2016: 13 · 2015: 3
FWCI: 18.16
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: academic.oup.com/pages/standard-publication-reuse-rights (vor)
Locations: American Journal of Respiratory Cell and Molecular Biology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Brigham and Women's Hospital
U.S. Public Health Service (CIA123046)
National Heart, Lung, and Blood Institute (HL114501, HL105339, R01HL086814, P01HL105339, AI111475-01, HL086814, R21HL111835, HL111835, HL063137, R01HL063137, T32HL007633, P01HL114501)
National Institute of Allergy and Infectious Diseases (R01AI111475, AI111475‐01)
National Institute of Environmental Health Sciences (P30ES007033)
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
Keywords: idiopathic pulmonary fibrosis, matrix metalloproteinases, tissue inhibitors of metalloproteinases, MMP-3, MMP-7, MMP-8, MMP-9, MMP-13, MMP-19, epithelial-mesenchymal transition, macrophage polarization, extracellular matrix degradation, therapeutic target, antifibrotic mechanism
MeSH terms: Animals, Cell Movement, Disease Models, Animal, Extracellular Matrix, Gene Expression Regulation, Humans, Lung, Signal Transduction, Randomized Controlled Trials as Topic, Macrophages, Alveolar, Mice, Matrix Metalloproteinases, Secreted, Idiopathic Pulmonary Fibrosis, Epithelial-Mesenchymal Transition, Molecular Targeted Therapy, Matrix Metalloproteinase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Matrix Metalloproteinases as Therapeutic Targets for Idiopathic Pulmonary Fibrosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks